Point72 Asset Management
CINC

Point72 Asset Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Point72 Asset Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-116,800
Closed -$1.44M – 2623
2022
Q4 		$1.44M Buy
+116,800
New +$2.78M ﹤0.01% 994

Point72 Asset Management's CINC Position: Q1 2023 in Review

Point72 Asset Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 116,800 shares — an estimated $1.44M sold.

Point72 Asset Management first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $1.44M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Point72 Asset Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Point72 Asset Management sold 116,800 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.44M.
  • Point72 Asset Management first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Point72 Asset Management's CinCor Pharma, Inc. Common Stock position peaked at $1.44M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Point72 Asset Management's 13F filing for Q1 2023, filed 15 May 2023.